David Walling - Collaborative NeuroScience Network, Inc

基本信息

浏览量：38

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 84 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Population Pharmacokinetic Analysis to Support and Facilitate Switching from Risperidone Formulations to Rykindo in Patients with Schizophrenia

Wenyan Wang, Xiaofeng Wang, Ying Dong,David P. Walling,Pinglan Liu,Wanhui Liu,Yanan Shi,Kaoxiang Sun

Neurology and Therapyno. 2 (2024): 355-372

引用0浏览0WOS引用

Effects of the Selective AMPA Modulator NBI‐1065845 on the Pharmacokinetics of Midazolam or Ethinyl Estradiol–levonorgestrel in Healthy Adults

Swan Lin, Adrian Ionescu, Jessica Maynard-Scott, Mike Kennedy,David P. Walling,Maura Furey,Jaskaran B. Singh

Clinical and translational scienceno. 5 (2024): e13791-e13791

引用0浏览0WOS引用

Cognitive Effects, Pharmacokinetics, and Safety of Zuranolone Administered Alone or with Alprazolam or Ethanol in Healthy Adults in a Phase 1 Trial

Joi Dunbar,David P. Walling,Howard A. Hassman,Rakesh Jain, Andy Czysz,Indrani Nandy, Victor Ona, Margaret K. Moseley,Seth Levin,Paul Maruff

JOURNAL OF PSYCHOPHARMACOLOGYno. 12 (2024): 1122-1136

引用0浏览0WOS引用

Efficacy and Safety of Xanomeline-Trospium Chloride in Schizophrenia

Inder Kaul,Sharon Sawchak,David P. Walling, Carol A. Tamminga,Alan Breier,Haiyuan Zhu,Andrew C. Miller,Steven M. Paul,Stephen K. Brannan

JAMA PSYCHIATRY（2024）

引用7浏览0WOS引用

Efficacy of Xanomeline and Trospium Chloride in Schizophrenia: Pooled Results from Three 5-Week, Randomized, Double-Blind, Placebo-Controlled, EMERGENT Trials

Inder Kaul,Sharon Sawchak,Amy Claxton,Colin Sauder, Howard H. Hassman,Rishi Kakar,David P. Walling,Leslie Citrome,Haiyuan Zhu,Andrew C. Miller,Stephen K. Brannan

SCHIZOPHRENIA（2024）

引用0浏览0WOSNATURE引用

An Open-Label Study to Assess Monthly Risperidone Injections (180 Mg) Following Switch from Daily Oral Risperidone (6 Mg) in Stable Schizophrenic Patients

David P. Walling,Sunita N. Shinde, Janice M. Pogoda,Jahnavi Kharidia,Celine M. Laffont

CLINICAL DRUG INVESTIGATION（2024）

引用0浏览0WOS引用

Pharmacokinetics and Safety of a Novel Extended-Release Microsphere Formulation of Risperidone in Patients with Schizophrenia or Schizoaffective Disorder

David P. Walling, Ying Dong,Robert Litman,Wenyan Wang, Chunli Liu, Joe Tai,Pinglan Liu,Yanan Shi,Wanhui Liu,Fenghua Fu,Kaoxiang Sun

JOURNAL OF CLINICAL PHARMACOLOGY (2024)

引用0浏览0WOS引用

A Randomized, Double-Blind, Multicenter, Noninferiority Study Comparing Paliperidone Palmitate 6-Month Versus the 3-Month Long-Acting Injectable in Patients with Schizophrenia

Dean Najarian,Panna Sanga,Steven Wang,Pilar Lim,Arun Singh, Mary Jane Robertson, Kristin Cohen,Alain Schotte, Ruth Milz,Raja Venkatasubramanian,Huybrecht T'Jollyn,David P. Walling,Silvana Galderisi,Srihari Gopal

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY（2022）

引用38浏览0WOS引用

Efficacy and Safety of Roluperidone for the Treatment of Negative Symptoms of Schizophrenia

Michael Davidson,Jay Saoud,Corinne Staner,Nadine Noel,Sandra Werner,Elisabeth Luthringer,David Walling,Mark Weiser,Philip D. Harvey,Gregory P. Strauss,Remy Luthringer

Schizophrenia Bulletin（2022）

引用30浏览0WOS引用

Emraclidine, a Novel Positive Allosteric Modulator of Cholinergic M4 Receptors, for the Treatment of Schizophrenia: a Two-Part, Randomised, Double-Blind, Placebo-Controlled, Phase 1b Trial

John H. Krystal,John M. Kane,Christoph U. Correll,David P. Walling,Matthew Leoni,Sridhar Duvvuri, Shrinal Patel,Ih Chang,Philip Iredale,Lillian Frohlich,Stacey Versavel,Pamela Perry,Raymond Sanchez,John Renger

The Lancet（2022）

引用58浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn